TMEM191B-like: A Transmembrane Protein with Potential as A Drug Target and Biomarker

Target Name: TMEM191B

NCBI ID: G728229

Other Name(s): transmembrane protein 191B-like | Transmembrane protein 191B | T191B_HUMAN | transmembrane protein 191B

TMEM191B-like: A Transmembrane Protein with Potential as A Drug Target and Biomarker

TMEM191B-like is a transmembrane protein that is expressed in various tissues and cells throughout the body. It is characterized by a unique domain structure that is similar to that of transmembrane proteins, such asTMEM120, TMEM44, and TMEM182. TMEM191B-like is expressed in a variety of tissues, including the brain, heart, liver, and pancreas, and has been shown to play a role in several cellular processes, including cell signaling, inflammation, and metabolism.

One of the key features of TMEM191B-like is its ability to form a homotetrically arranged transmembrane structure. This is achieved through the presence of a unique transmembrane segment, known as the N-terminal region, which contains a conserved amino acid sequence that is involved in the formation of a transmembrane ternary structure. The N-terminal region is followed by a variable-length cytoplasmic tail, which is also involved in the formation of the transmembrane structure.

The unique structure of TMEM191B-like has led to its potential as a drug target. Several studies have shown that TMEM191B-like can be targeted by small molecules, including inhibitors of tyrosine kinase activity and modulators of ion channels. Additionally, TMEM191B-like has been shown to play a role in several diseases, including neurodegenerative diseases, diabetes, and cancer.

One of the potential benefits of targeting TMEM191B-like is its potential to modulate ion channels that are involved in the regulation of ion transport and cell signaling. This can lead to a variety of potential therapeutic effects, including the inhibition of neurotransmitter release, the modulation of cellular signaling pathways, and the regulation of ion homeostasis.

In addition to its potential as a drug target, TMEM191B-like has also been shown to be involved in several cellular processes that are important for normal cellular function. For example, TMEM191B-like has been shown to play a role in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and the development of tissues. Additionally, TMEM191B-like has been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth and differentiation.

Another potential therapeutic application of TMEM191B-like is its use as a biomarker for the diagnosis and monitoring of disease. Several studies have shown that TMEM191B-like is expressed in a variety of tissues and cells, including those affected by neurodegenerative diseases, diabetes, and cancer. This makes it a potential biomarker for these diseases, as the expression of TMEM191B-like may be sensitive to changes in the levels of this protein in the affected tissue.

In conclusion, TMEM191B-like is a unique and highly conserved transmembrane protein that is expressed in a variety of tissues and cells throughout the body. Its unique structure and ability to form a transmembrane structure make it a potential drug target, and its involvement in several cellular processes makes it a potential biomarker for the diagnosis and monitoring of disease. Further research is needed to fully understand the role of TMEM191B-like in cellular processes and its potential as a therapeutic agent.

Protein Name: Transmembrane Protein 191B

More Common Targets